Abstract
Garcinol, a nicotinic acetylcholine receptor (nAChR) antagonist, has recently been established as an anti-inflammation agent. However, the molecular mechanism by which garcinol suppresses inflammation in the context of acute myocardial infarction (AMI) remains unclear. Hypothesis: We hypothesized that the administration of physiological doses of garcinol in mice with isoproterenol-induced AMI decreased the effect of lipoprotein(a) (Lp(a))-induced inflammation both in vivo and in vitro via the α7-nAChRs mediated p38 mitogen-activated protein kinase (MAPK)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling pathway. We analyzed altered reactive oxygen species (ROS) generation, the production of superoxide by mitochondria, cytokine expression patterns, and the role of the p38 MAPK/NF-κB signaling pathway after Lp(a)-stimulated human ventricular cardiomyocyte AC16 cells were treated with increasing doses of garcinol. C-reactive protein (CRP), interleukin (IL)-1β, IL-6, or tumor necrosis factor (TNF)-α production were detected by enzyme-linked immunosorbent assay. The Cell Counting Kit-8 assay was used to evaluate drug cytotoxicity. Western blots and confocal fluorescence microscopy were used to determine altered expression patterns of inflammatory biomarkers. We also examined whether the therapeutic effect of garcinol in AMI was mediated in part by α7-nAChR. Lp(a)-induced inflammatory cardiomyocytes had increased expression of membrane-bound α7-nAChRs in vitro and in vivo. Low-dose garcinol did not affect cardiomyocyte viability but significantly reduced mitochondrial ROS, CRP, IL-1β, IL-6, and TNF-α production in Lp(a)-stimulated cardiomyocytes (p < 0.05). The Lp(a)-induced phosphorylation of p38 MAPKs, CamKII, and NFκB, as well as NFκB-p65 nuclear translocation, was also suppressed (p < 0.05) by garcinol, while the inhibition of p38 MAPK by the inhibitor SB203580 decreased the phosphorylation of extracellular signal-regulated kinase (ERK) and p38 MAPK. Garcinol protected cardiomyocytes by inhibiting apoptosis and inflammation in mice with AMI. Furthermore, garcinol also enhanced the expression of microRNA-205 that suppressed the α7-nAChR-induced p38 MAPK/NF-κB signaling pathway. Garcinol suppresses Lp(a)-induced oxidative stress and inflammatory cytokines by α7-nAChR-mediated inhibition of p38 MAPK/NF-κB signaling in cardiomyocyte AC16 cells and isoproterenol-induced AMI mice.
Highlights
Acute myocardial infarction (AMI) with the subsequent cardiomyocyte apoptosis and adverse left ventricular remodeling constitutes the structural basis for ischemic heart failure [1], during which stressed cardiomyocytes due to hypoxia and ischemia can trigger the inflammatory response [2]
To examine the effect of Lp(a) on cell viability of human ventricular cardiomyocyte, AC16 were treated with increasing concentration of Lp(a) up to 10 μM
We found that garcinol suppressed Lp(a)/α7-nicotinic acetylcholine receptor (nAChR)-mediated cardiomyocyte apoptosis and inflammation in the human cardiomyocyte AC16 cells and mouse models of isoproterenol-induced acute myocardial infarction (AMI) through inhibition of Insulin-Like Growth Factor 2 Receptor (IGF2R), p-Glycogen Synthase Kinase (GSK)-3β/NF-κB, p-calmodulin-dependent kinase II (CamKII)/pERK/p-p38 mitogen-activated protein kinase (MAPK), RhoA-GTP signaling pathway, and reduced the production of IL-6, tumor necrosis factor (TNF)-α, and C-reactive protein (CRP)
Summary
Acute myocardial infarction (AMI) with the subsequent cardiomyocyte apoptosis and adverse left ventricular remodeling constitutes the structural basis for ischemic heart failure [1], during which stressed cardiomyocytes due to hypoxia and ischemia can trigger the inflammatory response [2]. Restoration of blood flow may further augment tissue damage via reperfusion injury due to abrupt re-oxygenation and reactive oxygen species (ROS) [2]. Timely coronary reperfusion is the most effective way of limiting myocardial injury, therapeutic manipulation of the ensuing tissue inflammation and its subsequent active suppression and resolution, remains elusive [2]. Lp(a) is a genetically determined causal factor for AMI [3]. While the risk of AMI increased with increasing Lp(a) concentrations, which is independent of Lp(a) isoform size, Lp(a) concentration and isoform size varied markedly between ethnic groups [4].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.